Skip to main content

Nanomedicine

Emerging Prospects

  • Book
  • © 2023

Overview

  • Highlights the emerging paradigm of nanomedicine, intersecting two important fields of nanotechnology and medicine
  • Provides a review on recent advancements of nanomedicine in the aforementioned emerging areas of nanomedicine
  • Presents the tools of nanotechnology to diagnose, prevent/treat diseases using biocompatible nanoparticles (NPs)

Part of the book series: SpringerBriefs in Applied Sciences and Technology (BRIEFSAPPLSCIENCES)

Part of the book sub series: Nanotheranostics (BRIEFSNANO)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 34.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 44.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (6 chapters)

Keywords

About this book

This book highlights the emerging paradigm of nanomedicine, intersecting two burgeoning fields of nanotechnology and medicine. Numerous publications have appeared in the literature over the years, especially in cancer nanomedicine. In a boarder sense, nanomedicine aims to apply the knowledge and tools of nanotechnology in a mission to diagnose early and prevent or treat diseases using biocompatible nanoparticles (NPs). Current research in nanomedicine and its prospects depend on creating new breakthroughs at the nexus of nanomaterials and biological systems, making use of non-toxic NPs and nano/biomaterials as smart theranostic systems for a variety of diseases including cancer, neurodegenerative, orthopedic, and cardiac diseases.  This book provides a review on recent advancements of nanomedicine in the aforementioned emerging areas of nanomedicine.​

Authors and Affiliations

  • Alpha Biomedical Pte Ltd, Singapore, Singapore

    Subramanian Tamil Selvan

About the author

Dr. Subramanian Tamil Selvan has over 25 years of research and teaching experience in nanomaterials and nanobiotechnology. Currently, he is a Chief Technology Officer and Chief Scientist at GSC & Alpha Biomedical Labs, Singapore. Earlier, he worked as a Principal Scientist (A*STAR Singapore), an Adjunct Associate Professor (NUS) and a Visiting Professor (KIST South Korea). His research covers a wide range of multifunctional nanoparticles and nanocomposites for diverse biomedical, energy and environment applications. He has authored over 100 publications and 1 book with a citation index of over 7000 and an h-index of 39.  He is an inventor of 7 awarded patents (5 USA, 1 Europe, and 1 Korea) in nanomaterials.

Bibliographic Information

Publish with us